Resultados de la búsqueda 241-250 of 11373 for Raised white cell count

  1. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer. A Study ...

  2. Cirugía - Ensayos clínicos - Mayo Clinic

    H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer. Human Blood ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This may lead to an increased risk of serious infections requiring hospitalization and an increased risk of secondary non-blood-based (hematologic) cancers.

  4. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer. A Study ...

  5. Hematología - Ensayos clínicos - Mayo Clinic

    This is a peripheral blood Collection Protocol to study the T-cell ... high (80-90%) frequency of MUC1 ... count ≥ 1,500 /microliter, and platelets ...

  6. Cirugía - Ensayos clínicos - Mayo Clinic

    H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer. Human Blood ...

  7. Hematología - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a peripheral blood Collection Protocol to study the T-cell ... high (80-90%) frequency of MUC1 ... count ≥ 1,500 /microliter, and platelets ...

  9. Cirugía - Ensayos clínicos - Mayo Clinic

    H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of increasing immune response and protecting against breast cancer. A Study ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This may lead to an increased risk of serious infections requiring hospitalization and an increased risk of secondary non-blood-based (hematologic) cancers.